共 148 条
[1]
Binns-Hall O(2018)One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot Diabet Med 35 887-894
[2]
Selvarajah D(2021)Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy Nat Rev Endocrinol 17 400-420
[3]
Sanger D(2011)Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K Diabetes Care 34 2220-2224
[4]
Walker J(2000)Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life Diabetes Res Clin Pract 47 123-128
[5]
Scott A(2006)The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes Diabetes Care 29 1518-1522
[6]
Tesfaye S(2006)Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives J Pain 7 892-900
[7]
Sloan G(2014)The contributors of emotional distress in painful diabetic neuropathy Diab Vasc Dis Res 11 218-225
[8]
Selvarajah D(2022)Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial Lancet 400 680-690
[9]
Tesfaye S(2015)Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy J Diabetes Complications 29 212-217
[10]
Abbott CA(2018)Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark Diabetes Care 41 1068-1075